Eric Dietrich

710 total citations
45 papers, 467 citations indexed

About

Eric Dietrich is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Eric Dietrich has authored 45 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 16 papers in Internal Medicine and 8 papers in Surgery. Recurrent topics in Eric Dietrich's work include Atrial Fibrillation Management and Outcomes (17 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Blood Pressure and Hypertension Studies (9 papers). Eric Dietrich is often cited by papers focused on Atrial Fibrillation Management and Outcomes (17 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Blood Pressure and Hypertension Studies (9 papers). Eric Dietrich collaborates with scholars based in United States, Pakistan and Germany. Eric Dietrich's co-authors include John G. Gums, Haesuk Park, Ghadeer K. Dawwas, Steven M. Smith, James R. Taylor, Joshua D. Brown, Jason Powell, Carl J. Pepine, Kyle Davis and Wei‐Hsuan Lo‐Ciganic and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Eric Dietrich

43 papers receiving 448 citations

Peers

Eric Dietrich

CCM

PHARM

SURGE

Niteesh K. Choudhry United States

Lance J. Oyen United States

Mary Loverde United States

Aileen B Luzier United States

Calvin H. Knowlton United States

Randall D. Seifert United States

Jane Skov Denmark

Mariano de la Figuera Spain

Linda R. Tulner Netherlands

Joel C. Marrs United States

Niteesh K. Choudhry United States

Eric Dietrich

216 ×1.0

CCM

77 ×0.6

67 ×0.8

PHARM

59 ×1.0

36 ×0.6

SURGE

Citations per year, relative to Eric Dietrich Eric Dietrich (= 1×) peers Niteesh K. Choudhry

Countries citing papers authored by Eric Dietrich

Since Specialization

Citations

This map shows the geographic impact of Eric Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Dietrich more than expected).

Fields of papers citing papers by Eric Dietrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Dietrich. The network helps show where Eric Dietrich may publish in the future.

Co-authorship network of co-authors of Eric Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Dietrich. A scholar is included among the top collaborators of Eric Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Dietrich. Eric Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Steven M., et al.. (2023). Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors among patients with heart failure with preserved ejection fraction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(10). 1024–1031. 1 indexed citations

Dietrich, Eric, et al.. (2023). Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism. Clinical and Translational Science. 16(6). 946–954. 2 indexed citations

Dietrich, Eric, et al.. (2023). Financial reimbursement and productivity metrics for pharmacist-led chronic care management services in rural practice settings. Research in Social and Administrative Pharmacy. 19(5). 778–782. 3 indexed citations

Jones, Bobby L., et al.. (2023). Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding. Research and Practice in Thrombosis and Haemostasis. 7(3). 100131–100131. 1 indexed citations

Smith, Steven M., et al.. (2021). Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(9). 710–721.

Middleton, Kimberly R., et al.. (2021). Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic. SHILAP Revista de lepidopterología. 5. 100098–100098.

Desai, Raj, Eric Dietrich, Haesuk Park, & Steven M. Smith. (2020). Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States. American Journal of Hypertension. 33(11). 999–1002. 6 indexed citations

Dawwas, Ghadeer K., Eric Dietrich, Steven M. Smith, Kyle Davis, & Haesuk Park. (2020). Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. Clinical Therapeutics. 42(9). e161–e176. 4 indexed citations

Desai, Raj, Haesuk Park, Eric Dietrich, & Steven M. Smith. (2020). Trends in ambulatory blood pressure monitoring use for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008–2017. SHILAP Revista de lepidopterología. 6. 100033–100033. 10 indexed citations

10.

Dietrich, Eric, et al.. (2019). Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace. Journal of Clinical Hypertension. 22(1). 6–15. 12 indexed citations

11.

Patel, Vishal, et al.. (2019). Effects of Oral Ginger Supplementation on the INR. Case Reports in Medicine. 2019. 1–2. 13 indexed citations

12.

Dietrich, Eric, et al.. (2019). Comparison of Factors Identified by Patients and Physicians Associated with Hospital Readmission (COMPARE2). Southern Medical Journal. 112(4). 244–250. 4 indexed citations

13.

Dawwas, Ghadeer K., Joshua D. Brown, Eric Dietrich, & Haesuk Park. (2018). Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis. The Lancet Haematology. 6(1). e20–e28. 61 indexed citations

14.

Hwang, Andrew Y., Eric Dietrich, Carl J. Pepine, & Steven M. Smith. (2017). Resistant Hypertension: Mechanisms and Treatment. Current Hypertension Reports. 19(7). 56–56. 27 indexed citations

15.

Carris, Nicholas W., Andrew Y. Hwang, Steven M. Smith, et al.. (2016). Patient satisfaction with extended-interval warfarin monitoring. Journal of Thrombosis and Thrombolysis. 42(4). 486–493. 8 indexed citations

16.

Smith, Steven M., Nicholas W. Carris, Eric Dietrich, et al.. (2016). Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension. Journal of the American Society of Hypertension. 10(4). 307–317. 26 indexed citations

17.

Kuritzky, Louis, et al.. (2015). Diagnosing and treating neurogenic orthostatic hypotension in primary care. Postgraduate Medicine. 127(7). 702–715. 9 indexed citations

18.

Taylor, James R., et al.. (2013). Lorcaserin for weight management. Diabetes Metabolic Syndrome and Obesity. 6. 209–209. 15 indexed citations

19.

Taylor, James R., Eric Dietrich, & Jason Powell. (2013). New and Emerging Pharmacologic Therapies for Type 2 Diabetes, Dyslipidemia, and Obesity. Clinical Therapeutics. 35(1). A3–A17. 22 indexed citations

20.

Dietrich, Eric, Jason Powell, & James R. Taylor. (2013). Canagliflozin: a novel treatment option for type 2 diabetes. Drug Design Development and Therapy. 7. 1399–1399. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact